e-learning
resources
European Respiratory Review
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151.
Source:
Eur Respir Rev 2012 21: 263
Journal Issue:
September 2012 - 21 (125)
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
“ASSESSING THE TREATMENT EFFECT FROM MULTIPLE TRIALS IN IDIOPATHIC PULMONARY FIBROSIS.” L. RICHELDI. EUR RESPIR REV 2012; 21: 147–151.. Eur Respir Rev 2012 21: 263
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
SURVIVAL OF THE IDIOPATHIC PULMONARY FIBROSIS (IPF) IN SPAIN. NATIONAL SEPAR REGISTRY
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY.
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
INVASIVE PULMONARY ASPERGILLOSIS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. P. BULPA, A. DIVE AND Y. SIBILLE. EUR RESPIR J 2007; 30: 782 800.
Source: Eur Respir J 2007; 30: 1236
Year: 2007
EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES.
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
IMPACT OF CHRONIC ANEMIA ON THE EVOLUTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE EXACERBATION (COPDE)
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ACCORDING TO STRENGTH IN UPPER LIMBS
Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases
Year: 2019
EVALUATION OF THE PALLIATIVE CRITERIA IN IDIOPATHIC PULMONARY FIBROSIS
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
HYPERCAPNIA AND FUNCTIONAL IMPROVEMENTS DURING PULMONARY REHABILITATION.
Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients
Year: 2021
NONTUBERCULOUS MYCOBACTERIA IN BRONCHIECTASIS: PREVALENCE AND PATIENT CHARACTERISTICS.
Source: Eur Respir J 2007; 29: 614-615
Year: 2007
BECLOMETHASONE/FORMOTEROL VERSUS BUDESONIDE/FORMOTEROL COMBINATION THERAPY IN ASTHMA. A. PAPI, P.L. PAGGIARO, G. NICOLINI, A.M. VIGNOLA AND L.M. FABBRI ON BEHALF OF THE INHALED COMBINATION ASTHMA TREATMENT VERSUS SYMBICORT (ICAT SY) STUDY GROUP. EUR
Source: Eur Respir J 2007; 29: 1286
Year: 2007
PULMONARY REHABILITATION AFTER LUNG TRANSPLANTATION: DEVELOPMENT OF A PROTOCOL
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
ANGIOTENSIN II BLOCKERS IN OBSTRUCTIVE PULMONARY DISEASE: A RANDOMISED CONTROLLED TRIAL.
Source: Eur Respir J 2006; 28: 1292
Year: 2006
LUNG TRANSTHORACIC ULTRASOUND (TUS) ELASTOGRAPHY: USEFULNESS IN THE STUDY OF PLEURO-PULMONARY IMAGES SUSPECTED OF MALIGNANCY
Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Year: 2018
PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
DIFFERENCES IN HOSPITAL COURSE IN COMMUNITY ACQUIRED PNEUMONIA (CAP) ACCORDING TO ANTIBIOTIC TREATMENT
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE.
Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Year: 2020
"PROGRESSION OF SNORING AND OBSTRUCTIVE SLEEP APNOEA: THE ROLE OF INCREASING WEIGHT AND TIME". G. BERGER, R. BERGER AND A. OKSENBERG. EUR RESPIR J 2009; 33: 338-345.
Source: Eur Respir J 2009; 33: 947
Year: 2009
DECREASED PULMONRY VASCULAR DISTENSIBILITY IN ADOLESCENTS CONCEIVED BY ASSISTED REPRODUCTIVE TECHNOLOGIES.
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
PROGNOSTIC FACTORS FOR SUCCESSFUL ADHERENCE WITH NON-INVASIVE MECHANICAL VENTILATION THERAPY.
Source: International Congress 2018 – Non-invasive ventilation in chronic respiratory failure
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept